Prochlorperazine
Brand names: Stemetil, Buccastem (buccal)
Prochlorperazine is a phenothiazine used for nausea and vomiting and for vertigo, including in labyrinthine disorders such as Meniere's disease.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UK(For children’s dosage and administration, see below.) Dosage should be increased more gradually in debilitated or emaciated patients. Elderly Patients: In general, dosages in the lower range are sufficient for most elderly patients. Since they appear to be more susceptible to hypotension and neuromuscular reactions, such patients should be observed closely. Dosage should be tailored to the individual, response carefully monitored and dosage adjusted accordingly. Dosage should be increased more gradually in elderly patients. 1.To Control Severe Nausea and Vomiting: Adjust dosage to the response of the individual. Begin with the lowest recommended dosage. Oral Dosage-Tablets: Usually one …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2025-01-22. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
It blocks dopamine D2 receptors (centrally, including the chemoreceptor trigger zone), reducing nausea and vertigo.
Prescribing in practice
- Extrapyramidal effects, especially acute dystonia in younger people, can occur — use with care and for the shortest time.
- Avoid using it to mask the cause of undiagnosed vomiting, particularly in children and young adults.
- It can prolong the QT interval and cause sedation and postural hypotension.
Monitoring
Review for movement disorders and the ongoing need.
Counselling the patient
- Report muscle spasms (especially of the face or neck), restlessness or abnormal movements.
- It can cause drowsiness.
Evidence & guidelines
Used for nausea, vomiting and vertigo, with caution about extrapyramidal effects.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020